TITLE

8 Steps to Take When Considering Antidepressants

AUTHOR(S)
Banov, Michael
PUB. DATE
May 2011
SOURCE
Positive Health;May2011, Issue 182, p1
SOURCE TYPE
Periodical
DOC. TYPE
Article
ABSTRACT
The article presents several steps one should and should not take when considering whether to start an antidepressant. According to the article, these steps are applicable no matter what kind of attitudes one already has about depression and antidepressants. Some of them include finding a professional, challenging authority and seeking other opinions.
ACCESSION #
65537209

 

Related Articles

  • Antidepressants and skin disease. Newbold, P.C.H. // British Medical Journal (Clinical Research Edition);2/6/1988, Vol. 296 Issue 6619, p379 

    Examines the relationship between chronic skin problems and depression. Use of antidepressants in treating skin diseases; Reduction of skin blood flow using antidepressant drugs; Benefits of doxepin on chronic urticaria and dermatographism patients.

  • Depression in Children and Adolescents.  // American Family Physician;11/15/2000, Vol. 62 Issue 10, p2297 

    Depression among children and adolescents is common but frequently unrecognized. It affects 2 percent of prepubertal children and 5 to 8 percent of adolescents. The clinical spectrum of the disease can range from simple sadness to a major depressive or bipolar disorder. Risk factors include a...

  • Unipolar Depression: Diagnostic and Therapeutic Recommendations From the Current S3/National Clinical Practice Guideline. HÄrter, Martin; Klesse, Christian; Bermejo, Isaac; Schneider, Frank; Berger, Mathias // Deutsches Aerzteblatt International;10/8/2010, Vol. 107 Issue 40, p3 

    The article discusses the diagnostic and therapeutic recommendations for unipolar depression from the national clinical practice guideline. Depressive disorders have a lifetime prevalence of 16 to 20 percent and is one of the most common pathologies and causes for health consultations in...

  • Antidepressants may not improve all symptoms of depression.  // Healthcare Counselling & Psychotherapy Journal;Jul2011, Vol. 11 Issue 3, p2 

    The article reports on research on depression which was conducted at the University of Texas Southwestern Medical Center and found that even people who have shown a positive treatment response to antidepressants continue to experience symptoms like insomnia, sadness and decreased concentration.

  • Proinflammatory cytokines: a common denominator in depression and somatic symptoms? Viljoen, Margaretha; Panzer, Annie // Canadian Journal of Psychiatry;Feb2005, Vol. 50 Issue 2, p128 

    Presents a letter to the editor about proinflammatory cytokines, which is a common denominator in depression and somatic symptoms.

  • New ways to defeat depression. Vreeland, Leslie // Good Housekeeping;Sep96, Vol. 223 Issue 3, p125 

    Presents several ways on how to fight depression. Things to consider before using an antidepressant. INSET: Warning signs..

  • Tricyelic antidepressants and selective serotonin reuptake inhibitors effective for depression in primary care.  // New Zealand Doctor;9/9/2009, p21 

    The article provides answers to a question on the effectiveness of tricyclic antidepressants and selective serotonin reuptake inhibitors in reducing depression in primary care.

  • Hugs, Not Depression Drugs. M. J. // Natural Solutions;Jun2010, Issue 126, p12 

    The article focuses on the result of a study featured in "The Journal of the American Medical Association" concerning the efficacy of psychotherapy compared to antidepressant drugs for treating depressed patients.

  • Does agomelatine have a place in the treatment of depression? Ambresin, Gilles; Gunn, Jane // BMJ: British Medical Journal;3/29/2014, Vol. 348 Issue 7951, p9 

    The author discusses a study by Taylor and colleagues on the efficacy of agomelatine promoted as an alternative to second generation antidepressants. It notes how the study underscores the importance of published and unpublished studies in any meta-analysis evaluating antidepressants as...

  • Reboxetine plus citalopram for refractory depression not responding to venlafaxine: possible mechanisms. Dursun, S.M.; Devarajan, S. // Psychopharmacology;2001, Vol. 153 Issue 4, p497 

    Reports on cases of patients with refractory depression (RD) who were venlafaxine non-responders but responded to the combination of reboxitine plus citalopram. Percentage of patients with major depression that fail to respond to any antidepressant monotherapies; Examples of combination therapy...

Share

Read the Article

Courtesy of THE LIBRARY OF VIRGINIA

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics